Device Trial Radar · NCT06604039
A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices
Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,500
Planned (sponsor's estimate)
Start
Dec 8, 2024
Primary completion
Dec 7, 2034
Study completion Dec 7, 2034
Sponsor
- Lead sponsor
- TeleflexPublic (TFX)
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes
Summary
As written by the sponsor on the registry.
The objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality data on the performance, safety, and clinical benefits of Teleflex's vascular access devices when used in a real-world setting
Conditions
- Vascular Access Device
Interventions
Central venous catheterDevice
Placement of a medical device to gain entry into the bloodstream, typically through a vein or artery, for the purpose of administering fluids, medications, blood products, or for hemodialysis
Primary outcomes
What the sponsor says the trial is designed to measure.
- Catheter devices: successful use of the device without removal due to device-related adverse eventsTime frame: Within 7 days after subject device removal
- Arrow VPS Rhythm DXL catheter tip positioning system: Successful verification of catheter tip locationTime frame: Immediately after subject device removal
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Huntsville Hospital
Huntsville, Alabama · Recruiting
Loma Linda University Health
Loma Linda, California · Recruiting
Tufts Medical Center
Boston, Massachusetts · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.